Speech-Language Therapy for Primary Progressive Aphasia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people with primary progressive aphasia (PPA), a condition that affects speech and language skills. It focuses on bilingual individuals who speak both Spanish and Catalan or Spanish and English. The trial will test two speech-language therapies: Lexical Retrieval Training (LRT), which addresses word-finding difficulties, and Video-Implemented Script Training for Aphasia (VISTA), which aids in forming sentences. Participants will receive therapy in both languages, and researchers will observe their responses. Ideal candidates are bilinguals with PPA who experience speech difficulties and regularly use both languages. As an unphased trial, this study offers a unique opportunity for bilingual individuals to explore innovative therapies tailored to their specific language needs.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these speech-language interventions are safe for individuals with primary progressive aphasia?
Research shows that speech-language treatments like Lexical Retrieval Training (LRT) and Video-Implemented Script Training for Aphasia (VISTA) are generally safe for people with primary progressive aphasia (PPA).
For LRT, studies have examined various speech therapies for PPA and found them well-tolerated. One study showed that language interventions similar to LRT do not cause serious side effects. These therapies aim to help individuals regain some language abilities, which is crucial as PPA progresses.
VISTA also has a good safety record. Research on its use in people with various types of PPA found that it significantly aids language tasks without causing major side effects. This method uses videos to help people practice and improve their speech, proving effective for different forms of PPA.
Both treatments aim to enhance language and communication skills. Current studies suggest they are safe and beneficial for people with PPA, with no significant safety concerns reported.12345Why are researchers excited about this trial?
Researchers are excited about the Speech-Language Therapy for Primary Progressive Aphasia trial because it explores innovative techniques like Lexical Retrieval Training (LRT) and Video-Implemented Script Training for Aphasia (VISTA). Unlike traditional speech therapy, which often focuses on general communication skills, LRT targets specific naming difficulties for those with logopenic or semantic variant PPA, offering a more tailored approach. VISTA, on the other hand, uses video-based script training to help individuals with nonfluent/agrammatic PPA practice real-life conversations, providing a practical and engaging way to enhance communication. These targeted strategies could offer more personalized and effective improvements compared to existing treatments.
What evidence suggests that this trial's treatments could be effective for bilingual individuals with primary progressive aphasia?
Research has shown that both Lexical Retrieval Training (LRT) and Video-Implemented Script Training for Aphasia (VISTA) can help people with primary progressive aphasia (PPA) improve their language skills. In this trial, participants will join one of these treatment arms. LRT significantly aids people with PPA in naming objects, with improvements lasting even after treatment ends. This suggests LRT effectively addresses naming difficulties in PPA. VISTA, in contrast, focuses on enhancing smooth speech by having patients practice set dialogues. Early results indicate that VISTA helps people speak more naturally and fluently over time. Both treatments aim to tackle speech and language challenges in PPA, offering hope for better communication.678910
Who Is on the Research Team?
Stephanie M Grasso, Ph.D.
Principal Investigator
University of Texas at Austin
Miguel Ángel Santos Santos, MD, PhD
Principal Investigator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Are You a Good Fit for This Trial?
This trial is for bilingual individuals who speak Spanish and Catalan or Spanish and English, diagnosed with Primary Progressive Aphasia (PPA). Participants must have a certain level of cognitive function as measured by the Mini-Mental State Examination. Those with other central nervous system issues, significant sensory impairments, or prominent non-speech-language impairments cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment Phase 1
Participants receive tailored speech-language intervention in both languages for bilingual individuals with PPA
Treatment Phase 2
Continuation of speech-language intervention with further assessments
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Lexical Retrieval Training (LRT)
- Video-Implemented Script Training for Aphasia (VISTA)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas at Austin
Lead Sponsor
Hospital Clinic of Barcelona
Collaborator
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborator